Effects of Decreased Vitamin D and Accumulated Uremic Toxin on Human CYP3A4 Activity in Patients with End-Stage Renal Disease

By Tsujimoto Masayuki   Nagano Yui   Hosoda Satomi   Shiraishi Asuka   Miyoshi Ayaka   Hiraoka Shima   Furukubo Taku   Izumi Satoshi   Yamakawa Tomoyuki   Minegaki Tetsuya   Nishiguchi Kohshi  

Toxins, Vol. 5, Iss. 8, 2013-08 ,pp. : 1475-1485

MDPI

Access to resources Recommend Favorite

Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins

By Florens Nans   Calzada Catherine   Lyasko Egor   Juillard Laurent   Soulage Christophe O.  

Toxins, Vol. 8, Iss. 12, 2016-12 ,pp. : 376-376

MDPI

Access to resources Recommend Favorite

Protein-Bound Uremic Toxins: New Culprits of Cardiovascular Events in Chronic Kidney Disease Patients

By Ito Shunsuke   Yoshida Masayuki  

Toxins, Vol. 6, Iss. 2, 2014-02 ,pp. : 665-678

MDPI

Access to resources Recommend Favorite

The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease

By Sallée Marion   Dou Laetitia   Cerini Claire   Poitevin Stéphane   Brunet Philippe   Burtey Stéphane  

Toxins, Vol. 6, Iss. 3, 2014-03 ,pp. : 934-949

MDPI

Access to resources Recommend Favorite

Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine

By Hüsing Anna   Kabar Iyad   Schmidt Hartmut H.   Heinzow Hauke S.  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 18033-18053

MDPI

Access to resources Recommend Favorite